The value of contrast-enhanced ultrasound in percutaneous biopsy of retroperitoneal masses = Der Stellenwert des kontrastverstärkten Ultraschalls bei der perkutanen Biopsie retroperitonealer Raumforderungen

Purpose: To evaluate the diagnostic yield of contrast-enhanced ultrasound (CEUS)-guided biopsy of retroperitoneal masses (RMs). Materials and Methods: Between 2006 and 2023, 87 patients presented at our US center for biopsy of an RM. In all biopsies, CEUS was performed prior to the intervention. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zadeh, Ehsan Safai (VerfasserIn) , Görg, Mathis (VerfasserIn) , Görg, Christian (VerfasserIn) , Prosch, Helmut (VerfasserIn) , Trenker, Corinna (VerfasserIn) , Westhoff, Christina Carolin (VerfasserIn) , Dietrich, Christoph F. (VerfasserIn) , Raab, Nils (VerfasserIn) , Alhyari, Amjad (VerfasserIn) , Huber, Katharina Paulina (VerfasserIn) , Pochepnia, Svitlana (VerfasserIn) , Weber, Michael (VerfasserIn) , Findeisen, Hajo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025
In: Ultraschall in der Medizin
Year: 2025, Jahrgang: 46, Heft: 1, Pages: 66-72
ISSN:1438-8782
DOI:10.1055/a-2282-2353
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1055/a-2282-2353
Verlag, kostenfrei, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/a-2282-2353
Volltext
Verfasserangaben:Ehsan Safai Zadeh, Mathis Görg, Christian Görg, Helmut Prosch, Corinna Trenker, Christina Carolin Westhoff, Christoph F. Dietrich, Nils Raab, Amjad Alhyari, Katharina Huber, Svitlana Pochepnia, Michael Weber, Hajo Findeisen
Beschreibung
Zusammenfassung:Purpose: To evaluate the diagnostic yield of contrast-enhanced ultrasound (CEUS)-guided biopsy of retroperitoneal masses (RMs). Materials and Methods: Between 2006 and 2023, 87 patients presented at our US center for biopsy of an RM. In all biopsies, CEUS was performed prior to the intervention. The technical success rate of biopsy, the presence of diagnostic tissue in solid tumor biopsy samples, the accuracy of the biopsy and the occurrence of post-interventional complications were evaluated. Results: A US-guided biopsy could be conducted in 84/87 cases (96.6%). In 3/87 cases (3.4%), US-guided biopsy was impossible because the planned needle path was obstructed by vital structures. Of 84 lesions, 80 (95.2%) were solid lesions, and 4 (4.8%) were lesions containing fluid. In all solid tumors, 80/80 (100%), diagnostic vital tissue was successfully obtained. CEUS-guided biopsy showed a sensitivity of 93.2%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 72.2%, and a diagnostic accuracy of 94.2% for the differentiation between malignant and benign RMs. In one of the 84 cases (1.2%), there was a complication of postinterventional abdominal pain. Conclusion: Percutaneous CEUS-guided biopsy is a safe procedure with a high diagnostic yield and a low complication rate.</p>
Beschreibung:Gesehen am 16.09.2024
Beschreibung:Online Resource
ISSN:1438-8782
DOI:10.1055/a-2282-2353